At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
rTMS + Neuronavigationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Pain, Fatigue, Quality of Life, Cognitive Function and Mood in Fibromyalgia
In Brief
A clinical study evaluating rTMS + Neuronavigation for Fibromyalgia. Completed, enrolled 20 participants across 1 site.
Detailed Summary
This study aims to evaluate the effectiveness of 10 Hz neuronavigated repetitive transcranial magnetic stimulation (rTMS) to the left dorsolateral prefrontal cortex (DLPFC) on pain, stiffness, fatigue, depression/anxiety, quality of life and cognitive functions in fibromyalgia syndrome (FMS).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFibromyalgia
CountriesTurkey (Türkiye)
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedApr 2019
Enrollment StartApr 2019
Primary CompletionApr 2020
Study CompletionApr 2020
TodayJul 2026
First PostedApr 9, 2019
Enrollment StartApr 11, 2019
Primary CompletionApr 1, 2020
Study CompletionApr 10, 2020
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 7.2 years ago
Interventions
rTMS + Neuronavigationdevice
Repetitive Transcranial Magnetic Stimulation (Neuro-MS/D) + Neural Navigator